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Predictors of Cerebral Arteriovenous Malformation Mortality: A 
Single-center, Five-year Retrospective Study 
Patricio Garcia-Espinosa,1 Edgar Botello-Hernández,1 Gabriela Torres-Hernández,1 Clarissa Guerrero-Cavazos,1 Estefania Villareal-Garza,2 Andrea 
Flores-Rodriguez.1 
Abstract 
Background: Arteriovenous Malformations (AVMs) are abnormalities in intracranial vessels between the arterial and venous systems. This study aimed to 
identify the predictors of mortality in patients that presented to our hospital with AVMs, ruptured or unruptured, and correlate them to those available in 
the literature. Methods: An analytical, observational, retrospective study was performed to review data of patients with cerebral AVMs in the University 
Hospital “Dr José Eleuterio González” from January 2016 to December 2020. Clinical files were reviewed based on AVMs diagnosis according to the  
International Classification of Diseases 10th Revision, ICD-10. Variables were subjected to a univariate analysis and those found significant (p-value < 0.05) 
were subjected to a logistic regression. Results: A total of 80 patients were included in our study. Most of the participants were females (56.3%) and three 
were pregnant. The most common presenting symptom was holocranial headache (34 cases) occurring between the hours of 22:00 to 7:00. The most 
significant predictors of mortality were a total bleeding volume greater than 9.18 cm3 (p = 0.010), the presence of more than one symptom (p = 0.041), 
and a history of previous cerebral intraparenchymal hemorrhage (p = 0.014). Conclusion: Results demonstrated an important association between 
intracranial bleeding and mortality. Ultimately, more prospective studies are needed to determine predictor factors for mortality in AVMs patients. 
 




Arteriovenous Malformations (AVMs) are abnormalities in intracranial 
vessels between the arterial and venous systems.1 They consist of 
abnormal dilation of vascular structure, forming a nest between the 
two systems without capillaries, causing arterial blood to reach the 
venous system.2 In turn, the formed nest has its own circulation 
system, formed by its own arteries (referred to as vasa-vasorum); 
however, unlike healthy blood vessels, these lack normal innervation 
and therefore lack the ability to self-regulate arterial flow within the nest.3 
 
Although in adults AVMs are regarded as acquired malformations, in 
infants they are believed to be congenital.4 The pathogenesis of 
congenital AVMs is poorly understood. It is suggested that they develop 
during the embryogenesis of the primordial vascular system between 
the third and twelth week of gestation, and are therefore present at 
birth.4 The most common clinical presentation of cerebral AVMs in 
pediatric patients is sudden rupture. The first signs and symptoms are 
usually those associated with intracerebral hemorrhage in 41-79% of 
cases.5 We have not come across any epidemiological study to determine 
the most common cause of AVM onset in Mexican pediatric patients. 
 
The average age of AVM appearance is between the ages of 20 and 40, 
without specific gender prevalence.6 Despite being more common in 
adults, the probability of a rupture is comparatively lower in the adult 
population than in the pediatric one. However, rupture and consequent 
hemorrhage are still the most common cause of symptoms onset.6 
When left untreated, the probability of rupture ranges between 2.10-
4.12%.7 There is a suggested association between hormonal changes in 
puberty and AVM rupture, which is why it is believed that the hormonal 
changes of pregnancy could also represent a period of increased 
rupture risk.6  
 
The most important classification for cerebral AVMs was described by 
Spetzler and Martin in 1986, which is used to determine the most 
appropriate therapeutic approach for these patients.10 The Spetzler 
Martin Grading Scale ranges from I to VI, where Grade I represents a 
small, superficial malformation in a non-eloquent portion of the cortex, 
Grade V represents a large, deep malformation in an eloquent portion 
of the cortex, and Grade VI is inoperable. For the diagnosis and 
visualization of AVMs, angiography is considered to be the gold 
standard because it gives a visualization of the pathology that allows 
for both diagnostics and treatment planning.11,12 Initial visualization is 
intended to be non-invasive, for which Computed Tomography (CT) or 
Magnetic Resonance Imaging (MRI) are often used, especially in 
patients with diffuse or non-specific symptoms such as seizures or 
headaches. A CT scan is considered superior to MRI for observing 
vasculature, however, an MRI is a better choice for visualizing adjacent 
structures and planning treatment.13-15 
 
Therapeutic management includes different modalities of surgical 
resection, endovascular embolization, and stereotactic surgery 
(particularly in those with a nest size smaller than 3 cm at the largest 
diameter).16 Currently attempts have been made to develop a non-
invasive medical treatment, or a “wait-and-see” treatment approach, 
with little to no recovery period, for patients with unruptured AVM. 17,18 
 
Original Article  
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Current literature on this subject is not specific to the Mexican 
community or even the population of Centarl/South America in general. 
Due to the socio-demographic variants of this population, which are far 
from the economically developed societies of Northern America and 
Europe where most AVM studies have been performed, the literature 
cannot fully be generalized for the adult or pediatric AVM population of 
Mexico. In the current AVM literature, variables such as previous history 
of ruptured AVMs, pattern of venous drainage, and the location of the 
AVM itself have been found to be significant, however, these risk 
factors have been proposed mostly by singlecenter studies, and have 
not been always replicated, as highlighted by Rutledge WC, et al in 
2014.19 In addition, although some data is available in the Hispanic 
literature, they are of suboptimal quality, as they represent a low 
number of cases and do not show the results of all departments that 
may be involved in the review of ruptured AVMs.6,14 For this reason, the 
present study reviewed the experience of a single, tertiary-care centre 
in Mexico to seek a representation of the present phenomenon, to try 
to replicate results from the literature, and to give rise to further 
research in treating AVMs in the field with the objective of generating 
AVM epidemiological datasets from which predictors of mortalities 




This was an analytical, observational, retrospective study. A review of 
the clinical records for each participant was carried out by senior 
medical students. We included patient data from the last five years 
because that is the maximum time a patient’s file is kept after their 
hospitalization. Finally, an Excel database was created in order to 
extract relevant data using an Excel processor. Consent for publication 
and ethical approval came from the Ethical and Research Commitment 
from Hospital Universitario “Dr. José Eleuterio González” at Universidad 




We reviewed available data of patients who were hospitalized at the 
UANL, University Hospital from January 2016 to December 2020 for 
cerebral AVMs, regardless of whether their malformation had ruptured. 
The data was provided by the statistics department of our institution 
and the clinical files and CT images were reviewed by a neurology 
resident. In order to obtain all the existing patient data from our 
institution, patient files were identified using the following codes of the 
tenth revision of International Classification of Diseases (ICD-10): Q27, 
Q28, I60, I62 and I69 – with our main focus on Q28.20  
 
The sample was taken by convenience method of sampling since the 
studied sample was the total number patients who visited our center 
in the last five years. We included all patients from every department 
or division within our hospital who were diagnosed with a cerebral 
AVM. We excluded patients who were found  not have a cerebral AVM 
and whose pathology-oriented medical assessment revealed a 
differential diagnosis such as cavernous angioma or capillary 
telangiectasias, among others.  
 
Variables 
Clinical and demographic data obtained included  sex, age, time of 
symptoms evolution, treatment details, imaging findings, all other 
predictive factors that were previously known, and comorbidities. In 
addition, data extracted from patient registries included treatment 
outcome, subsequent or previous rupture at the time of diagnosis, 
number of hospitalization days, and time and place of rupture. The 
population studied was divided into those with a rupture and those 
without a rupture of an AVM at the moment of arrival in our institution. 
 
Statistical Analysis 
For the analysis, IBM SPSS Software 23.0 version,21 RStudio version 4.0.2 
(2020-06-22), and ggplot2 package were used. To compare the data 
between the groups, Student's-t test and Chi-squared test were used 
depending on the type of variable, T-test on variables with normal 
distribution and Chi-squared test on independent random variables 
with standard normal distribution. For correlations, Pearson’s 
correlation coefficient was reported. A p-value <0.05 was considered 
statistically significant. Variables that resulted in statistically significant 





Using the ICD-10 codes, a total of 486 files were obtained. After applying 
our inclusion and exclusion criteria, we included 80 patient files for 
subsequent analysis. The average age of our patients was 26.9 ± 17.5 
years, and just over half of the population was female N=45 (56.3%), 




Most common presenting symptom was holocranial headache, foundin 
34 (23.9%) patients, followed by a generalized tonic-clonic seizure in 29 
(20.4%) patients, and lastly a loss of consciousness in 24 (16.9%) 
patients. Only 6 (7.5%) patients presented without any symptoms, and 
1 (1.25%) patient had attended a scheduled consultation at the 
neurosurgery facility. A total of 47 (58.8%) patients presented with 
active bleeding from AVM rupture and a holocranial headache was the 
most common symptom reported, being present in 12 (25.7%) of these 
cases, followed by altered state of consciousness in 10 (21.2%) patients. 
The onset of symptomsoccurred between the hours of 22:00 to 7:00 in 
the majority of patients (61.3%), which are the hours that are regularly 
not dedicated to work or school in our country. At symptom onset, most 
patients were asleep, resting at home, or waking up. (Table 1) 
 
Relevant Past History  
Among comorbidities and predictive factors, the most common were 
the existence of previous cerebral intraparenchymal hemorrhage 
observed in 23 (28.7%) patients, followed by Type 2 Diabetes Mellitus 
as the second most common comorbidity in 15 (18.8%) patients, and 
Systemic Arterial Hypertension in third place in 14 (17.5%) patients. 
Inquiring more about personal history, we found that almost half of our 
included patients led a sedentary lifestyle or were smokers (45% and 
40%, respectively).  
 
Outcome 
The median AVM size was 10.29 cm3 (2.49 cm3 - 35.66 cm3). Forty-one 
(51.2%) had AVM on their right side, mainly found in the frontal lobe 
in 24 (30%) patients. The middle cerebral artery was the most common 
nutrient artery in 34 (32.1%) patients. In the venous system, the 
collateral veins of the superior sagittal sinus in 21 (20.8%) patients were 
the most commonly affected ones. For diagnosis and classification, CT 
scans were performed. For more detailed characteristics, consult Table 2. 
 
For treatment, angio-embolism alone, or accompanied by radiosurgery 
or surgical excision by craniotomy, were the most common treatment 
options (41 patients, 39.8%), followed by craniotomy in 37 (35.92%) and 
radiosurgery in 13 (12.6%) patients. A conservative approach was 
chosen by 12 (11.7%) patients, showing that the vast majority decided 
not to resort to the “wait-and-see” treatment (Table 1). 
 
Figure 1 illustrates AVMs size as a predictor of mortality. A total volume 
in cubic centimeters greater than 9.18 cm3 (OR 0.063 (0.008 - 0.519)), as 
well as the presence of more than one symptom (OR 4.022 (1.026 – 
15.467)), and a history of previous cerebral intraparenchymal 
hemorrhage (OR 4.533 (1.359 – 15.126)), were significant predictors 
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Table 1. General characteristics population.  
 
Characteristic n (%) 
Female gender 45 (56.3) 
Age in years† 26.9 ± 17.5 
Symptomatology  
Holocranial headache 34 (23.9) 
Tonic-Clonic Seizures 29 (20.4) 
Loss of Consciousness 24 (16.9) 
Hemibody paralysis 10 (7.0) 
Vomiting 9 (6.3) 
Asymptomatic 6 (4.2) 
Hemicranial headache 5 (3.5) 
Aphasia  4 (2.8) 
Other  21 (14.8) 
Comorbidities and Predictors  
Diabetes 15 (18.8) 
Hypertension 14 (17.5) 
Cancer 2 (2.5) 
BMI  
Obesity (> 30) 37 (46.3) 
Overweight (25 - 29.9) 32 (40.0) 
Normal weight (18.5 - 24.9) 11 (13.8) 
Smoker 32 (40.0) 
Sedentary lifestyle 36 (45.0) 
Pregnancy 3 (3.8) 
Event characteristics  
Temporality  
22:00 - 7:00 49 (61.3) 
7:01 – 21:59 31 (38.8) 
Place or action of the patient   
Asleep 22 (27.5) 
House 16 (20.0) 
Waking up 12 (15.0) 
Elective consultation 11 (13.8) 
Working, school 9 (11.3) 
Showering  6 (7.5) 
Exercising  3 (3.8) 
Street 1 (1.3) 
Hemorrhage  
All-age hemorrhage 47/80 (58.8) 
Pediatric hemorrhage (0 -17 years) 24/30 (80.0) 
Adult hemorrhage (≥18 years) 23/50 (46.0) 
Previous hemorrhage 23 (28.7) 
Posterior hemorrhage 10 (12.5) 
Treatment used  
Angio-embolism 41 (39.8) 
Surgical excision by craniotomy 37 (35.9) 
Radiosurgery 13 (12.6) 
Conservative management 12 (11.7) 
Mortality  
All-age mortality 14/80 (17.5) 
Pediatric mortality (0-17 years) 10/30 (33.3) 
Mortality in adults (≥18 years) 4/50 (8.0) 
 
Legend: † Represents the use of the mean and standard deviation to represent the data. 
 
Discussion 
This analytical, retrospective study analyzed AVM mortality risk factors 
in 80 patient files from University Hospital “Dr José Eleuterio González” 
from January 2016 to December 2020. 
Table 2. Characteristics of arteriovenous malformations 
 
Characteristic n (%) 
Laterality (n=80)  
Right 41 (51.2) 
Left 37 (46.3) 
Bilateral 2 (2.5) 
Cerebral location (n=80)  
Frontal 24 (30.0) 
Occipital 15 (18.8) 
Temporary 12 (15.0) 
Frontoparietal 8 (10.0) 
Frontotemporal 6 (7.5) 
Parietal 3 (3.8) 
Cerebellum 3 (3.8) 
Other  9 (11.3) 
Nutritional arteries (n=106)  
Deep middle cerebral artery 34 (32.1) 
Deep posterior cerebral artery 28 (26.4) 
Deep anterior cerebral artery 27 (25.5) 
Posterior inferior cerebellar artery 8 (7.5) 
Internal carotid artery 8 (7.5) 
Middle meningeal artery 1 (0.9) 
Venous drainage (n=101)  
Collaterals of the superior sagittal sinus 21 (20.8) 
Vein of Galen 14 (13.9) 
Deep circulation 10 (9.9) 
Superior longitudinal sinus 8 (7.9) 
Internal cerebral vein 8 (7.9) 
Superficial cerebral veins 8 (7.9) 
Other  32 (31.7) 
Spetzler-Martin arteriovenous malformation grading system  
I 7 (8.8) 
II 37 (46.3) 
III 19 (23.8) 
IV-VI 17 (21.3) 
 
Legend: * Represents the use of median and interquartile index to represent the data. 
Spetzler -Martin VI is not used in the institution part of this research. 
 
We found that the average age of AVM presentation was 26.8 years, 
with a slightly higher prevalence among the female sex. Obesity, Type 
2 Diabetes Mellitus, Systemic Arterial Hypertension, and sedentary 
lifestyle were present in a substantial part of the study cohort. The 
most significant predictors of mortality were a total volume greater than 
9.18 cm3, the presence of more than one symptom, and a history of 
previous cerebral intraparenchymal hemorrhage. The most common 
presenting symptom was a holocranial headache occurring between the 
hours of 22:00 to 7:00. The timing of symptomatology presentation, as 
a predictor of mortality, could be one of the most important findings of 
the present study. 
 
Our findings differ from those provided by the National Hospital of 
Neurology and Neurosurgery of Mexico, which report an average 
presenting age of 32.9 years and no gender predilection.22 We also 
found that holocranial headache was the most common presenting 
symptom which conicides with what was previously reported by 
Mariano Rinaldi in 2015.23 Rinaldi not only found that holocranial 
headache was most commonly reported at symptom onset, but that 
30.8% of patients were classified as Spetzler-Martin class III. We found 
that 23.8% of our patients were a class III Spetzler-Martin. It has been 
reported that grades I and II have good results with microsurgery, while 
grades III and IV mostly benefit from endovascular embolism.23 In our 
center, 68 (85%) subjects had a surgical approach, and at least 23 
(33.8%) shared an approach through craniotomy and/or radiosurgery in 
addition to angio-embolism. These approaches are in accordance with 
AHA 2017 recommendations for AVMs Spetzler-Martin III and IV.24 
 
We found other similarities to Rinaldi’s previously reported results, 
such as the distribution of AVMs towards the right side and mainly in 
the frontal lobe, in 51.2% and 30% of cases, respectively. Another 
important factor in this context was the patient's history of past 
cerebral intraparenchymal haemorrhage (28.7%), as it is one of the 
Original Article  
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variables that has been most represented in the literature as a predictor 
of mortality in bleeding AVMs, which our results replicate.23 
 
An interesting finding in our study was regarding pregnant women. 
According to what has been reported in the literature, it was found 
that, although rare, AVMs are responsible for about 50% of 
subarachnoid hemorrhages in pregnant women and are the third cause 
of non-obstetric maternal mortality. However, there are discrepancies 
in the literature regarding the influence of pregnancy on the natural 
history of AVM. 25,26,27 We did not find a higher mortality risk for 
pregnant patients in our study. Although it should be noted that the 
number of included pregnant patients in our study was small. 
 
Overall mortality in our sample of 80 patients was 17.5% (14 patients, 
10 pediatrics and 4 adults). The pediatric mortality was 33.3% (10 
patients out of 30). The adult mortality was only 8% (4 patients out of 
50). The mortality in the adult population is similar to those reported 
by Hillman, et al.28 and Rinaldi et al.23, who reported a 13.46% mortality 
rate. Other studies also reported a moratliy rate ranging from 10 to 
15%.17,22 However, the mortality in the pediatric population is vastly 
different from that of the literature, being 33.3% in our study and 12% 
in a study published by Riordan, et al.29 
Finally, hemorrhage is an important factor when it comes to mortality, 
which was the most common presentation in our study together with 
its associated symptomatology, the holocranial headache. Hemorrhage 
occured in 24 out of 30 pediatric patients, accounting for a pediatric 
hemorrhage mortality of 42%. While in adults hemorrhage was present 
in only 23 out of 50 patiens,  with a mortality rate of about 17%. High 
rates of bleeding in pediatrics could explain their high mortality rates. 
While in adults, the mortality in ruptured AVMs does approach the 10-
20% ratio in our study, which is consistent with what other authors 
have reported. 30,31  
 
Interestingly, the chronobiology of AVM’s rupture is not actually 
described in the literature, but it has been seen that in children the 
onset of symptoms can generally be found in the morning hours, 
regardless of their daily activities and waking up time.32,33,34 The time 
of symptomatology presentation has been highlighted as a poor 
prognostic factor in both children and adults in our study, without being 
demonstrated by the literature.32-38 We found a high prevalence of 
symptom onset in non-working hours, warranting a more specific 
analysis focusing on this parameter. 
 
Table 3. Odds ratio of the analyzed variables as predictors of mortality 
 
Characteristic Odds ratio (95% Confidence interval) p-value 
Arteriovenous Malformation Size   
Total area (cm3)   
≤9.18 cm 0.063 (0.008 - 0.519) 0.01 
>9.18 cm 16.00 (1.926 - 132-899) 0.01 
Length   
≤3.36 cm 0.150 (0.042 - 0.539) 0.004 
>3.36 cm 6,667 (1,854 - 23,973) 0.004 
Width   
≤1.92 cm 0.077 (0.010 - 0.622) 0.016 
>1.92 cm 13.00 (1.607 - 105.146) 0.016 
Depth   
≤1.77 cm 0.053 (0.006 - 0.439) 0.007 
>1.77 cm 18,947 (2,276 - 157-757) 0.007 
Number of symptoms   
≤1 symptom 0.242 (0.062 - 0.946) 0.041 
>1 symptom 4,022 (1,026 - 15,467) 0.041 
Hemorrhage   
Previous hemorrhage 4,533 (1,359 - 15,126) 0.014 
Current hemorrhage 12,235 (1,513 - 98,966) 0.019 
Posterior hemorrhage 2,299 (0.514 - 10.280) 0.276 
Laterality   
Left 1,192 (0.579 - 6.318) 0.288 
Right 0.590 (0.179 - 1.950) 0.387 
Bilateral 5.33 (0.683 - 41.622) 0.11 
Age   
≤ 17 years 5,750 (1,610 - 20,553) 0.007 
≥18 years 0.174 (0.049 - 0.621) 0.007 
Sex   
Female 0.737 (0.232 - 2.341) 0.605 
Male 1.357 (0.427 - 4.311) 0.605 
 
Legend: An odds ratio with a 95% confidence interval greater than 1 was interpreted as a clinically significant risk factor. On the contrary, a 95% confidence interval value less 
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Figure 1. Receiver operator curve of arteriovenous malformation size as a 























The main limitation of this study is that it is retrospective in nature. 
More ambispective and prospective studies are necessary in order to 
identify other potential predicting factors. Another limitation is that, 
due to the patient privacy rules of our hospital, patient files can only 
be kept for five years from their last visit, and thus no information was 
available for previous years. Finally, it is possible that not all AVMs 
were documented, since analysed clinical records do not always 
contain reliable and complete data. 
 
Conclusions 
In this study we presented the relationship between mortality and age. 
Despite the fact that AVMs are more common in adults, they have a 
lower mortality when compared to children. Because there is no 
research comparing paediatric and adult populations on this topic in 
Mexico, and few studies focused on AVMs in general, it is critical to 
underline the significance of this disease, which is considered silent 
but lethal when active bleeding occurs. Identifying epidemiological 
characteristics of the country's main tertiary care centres could serve 
as a springboard for more targeted and beneficial studies into the 
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